• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病细胞在受到特定 T 辅助细胞的刺激后会被激活并增殖。

Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.

机构信息

Centre for Immune Regulation, Department of Immunology, University of Oslo, Oslo University Hospital, Rikshospitalet, 0424 Oslo, Norway.

出版信息

Cell Rep. 2013 Aug 15;4(3):566-77. doi: 10.1016/j.celrep.2013.07.011. Epub 2013 Aug 8.

DOI:10.1016/j.celrep.2013.07.011
PMID:23933259
Abstract

There is increasing interest in the chronic lymphocytic leukemia (CLL) microenvironment and the mechanisms that may promote CLL cell survival and proliferation. A role for T helper (Th) cells has been suggested, but current evidence is only circumstantial. Here we show that CLL patients had memory Th cells that were specific for endogenous CLL antigens. These Th cells activated autologous CLL cell proliferation in vitro and in human → mouse xenograft experiments. Moreover, CLL cells were efficient antigen-presenting cells that could endocytose and process complex proteins through antigen uptake pathways, including the B cell receptor. Activation of CLL cells by Th cells was contact and CD40L dependent. The results suggest that CLL is driven by ongoing immune responses related to Th cell-CLL cell interaction. We propose that Th cells support malignant B cells and that they could be targeted in the treatment of CLL.

摘要

人们对慢性淋巴细胞白血病(CLL)微环境及其促进 CLL 细胞存活和增殖的机制越来越感兴趣。已经有人提出了辅助性 T 细胞(Th)的作用,但目前的证据只是间接的。在这里,我们发现 CLL 患者的记忆性 Th 细胞针对内源性 CLL 抗原具有特异性。这些 Th 细胞在体外和人源→鼠异种移植实验中激活了自身的 CLL 细胞增殖。此外,CLL 细胞是有效的抗原呈递细胞,可通过包括 B 细胞受体在内的抗原摄取途径内吞和加工复杂蛋白。Th 细胞通过细胞接触和 CD40L 依赖性激活 CLL 细胞。这些结果表明,CLL 是由与 Th 细胞-CLL 细胞相互作用相关的持续免疫反应驱动的。我们提出,Th 细胞支持恶性 B 细胞,并且它们可能成为 CLL 治疗的靶点。

相似文献

1
Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.慢性淋巴细胞白血病细胞在受到特定 T 辅助细胞的刺激后会被激活并增殖。
Cell Rep. 2013 Aug 15;4(3):566-77. doi: 10.1016/j.celrep.2013.07.011. Epub 2013 Aug 8.
2
Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.慢性淋巴细胞白血病细胞通过T-bet依赖机制对Th1细胞衍生的IFN-γ作出反应,从而表达CD38。
J Immunol. 2015 Jan 15;194(2):827-35. doi: 10.4049/jimmunol.1401350. Epub 2014 Dec 10.
3
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.活化的自体T细胞在体外和体内均发挥抗B细胞慢性淋巴细胞白血病的作用。
Cytotherapy. 2009;11(1):86-96. doi: 10.1080/14653240802666035.
4
Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.与活化的CD4(+) T细胞的直接细胞相互作用可克服体外B细胞慢性淋巴细胞白血病的低反应性。
Cell Immunol. 1998 Oct 10;189(1):41-50. doi: 10.1006/cimm.1998.1360.
5
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.自体T细胞可控制人源化小鼠辐射嵌合体中B细胞慢性淋巴细胞白血病的肿瘤进展。
Cancer Res. 1999 Dec 1;59(23):5968-74.
6
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.研究 CD38 及相关功能分子风险因素在 CLL NOD/SCID 异种移植模型中的作用。
Eur J Haematol. 2011 Jul;87(1):10-9. doi: 10.1111/j.1600-0609.2011.01626.x.
7
Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.使用经修饰的B细胞慢性淋巴细胞白血病(B-CLL)细胞作为刺激物,从HLA I类匹配供体中生成B-CLL反应性T细胞系和克隆:对过继性免疫治疗的意义
Leukemia. 2004 Jul;18(7):1278-87. doi: 10.1038/sj.leu.2403358.
8
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.一种新型慢性淋巴细胞白血病过继转移模型提示 T 淋巴细胞在疾病中起关键作用。
Blood. 2011 May 19;117(20):5463-72. doi: 10.1182/blood-2010-12-324210. Epub 2011 Mar 8.
9
Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.疾病进展期间及自体肿瘤细胞疫苗接种后慢性淋巴细胞白血病反应性T细胞
Clin Cancer Res. 2003 May;9(5):1656-65.
10
Immunobiology of chronic lymphocytic leukemia.慢性淋巴细胞白血病的免疫生物学
Hematol Oncol Clin North Am. 1990 Apr;4(2):405-29.

引用本文的文献

1
Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia.线粒体代谢对慢性淋巴细胞白血病T细胞功能障碍的影响
Front Cell Dev Biol. 2025 Apr 17;13:1577081. doi: 10.3389/fcell.2025.1577081. eCollection 2025.
2
Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0.血液中正常残留淋巴细胞群作为慢性淋巴细胞白血病Binet A/Rai 0期白血病细胞动力学的替代生物标志物
Cancers (Basel). 2025 Jan 21;17(3):347. doi: 10.3390/cancers17030347.
3
CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity.
CD38通过CD45磷酸酶活性调节慢性淋巴细胞白血病的增殖。
Mol Ther Oncol. 2024 Jun 24;32(3):200841. doi: 10.1016/j.omton.2024.200841. eCollection 2024 Sep 19.
4
Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia.优化体外 Th17 极化用于慢性淋巴细胞白血病的过继细胞治疗。
Int J Mol Sci. 2024 Jun 7;25(12):6324. doi: 10.3390/ijms25126324.
5
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.经工程改造表达 T 细胞因子的基质细胞在体外和 PDX 共移植中诱导强烈的 CLL 细胞增殖,从而鉴定 RAF 抑制剂作为抗增殖药物。
Leukemia. 2024 Aug;38(8):1699-1711. doi: 10.1038/s41375-024-02284-w. Epub 2024 Jun 14.
6
CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression.单克隆B淋巴细胞增多症和慢性淋巴细胞白血病中的CD20+ T细胞:频率、表型及其与疾病进展的关联
Front Oncol. 2024 Mar 28;14:1380648. doi: 10.3389/fonc.2024.1380648. eCollection 2024.
7
Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?慢性淋巴细胞白血病中的细胞外囊泡:作为新型靶向治疗基础的肿瘤微环境信使?
Cancers (Basel). 2023 Apr 14;15(8):2307. doi: 10.3390/cancers15082307.
8
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation.依鲁替尼通过阻断 TLR9 诱导的 CD40 上调和蛋白翻译使 CLL 细胞对 venetoclax 敏感。
Leukemia. 2023 Jun;37(6):1268-1276. doi: 10.1038/s41375-023-01898-w. Epub 2023 Apr 26.
9
NF-kB and the CLL microenvironment.核因子-κB与慢性淋巴细胞白血病微环境
Front Oncol. 2023 Mar 30;13:1169397. doi: 10.3389/fonc.2023.1169397. eCollection 2023.
10
The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?Th17 细胞在慢性淋巴细胞白血病中的作用:是敌是友?
Blood Adv. 2023 Jun 13;7(11):2401-2417. doi: 10.1182/bloodadvances.2022008985.